Tirisham Gyang is a Neurology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 38 publications with 256 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
56.7%Gabapentinoids24.1%Gabapentin82%Pregabalin18%Part D<11 patientsAnti-epileptic Agent7%Oxcarbazepine74%Primidone26%Part D<11 patients+ 7 more classes in this area
Musculoskeletal
28.8%gamma-Aminobutyric Acid-ergic Agonist16.5%Baclofen100%Part D≥27 patientsCentral alpha-2 Adrenergic Agonist12.3%Tizanidine Hcl100%Part D≥22 patientsCancer & immunology
8.8%CD20-directed Cytolytic Antibody4.5%Kesimpta Pen100%Part D<11 patientsOther immunosuppressants4.3%Vumerity50%Dimethyl Fumarate50%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Focal Motor Seizures as a Manifestation of Rheumatoid Meningitis
Neurology Neuroimmunology & Neuroinflammation
2026 - ANTI-CD19 MONOCLONAL ANTIBODY FOR SYSTEMIC LUPUS ERYTHEMATOSUS AND NEUROMYELITIS OPTICA SPECTRUM DISORDER
Lupus Science & Medicine
2025 - Factors Associated with Response, Neurotoxicity, and Survival in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-cell (CAR-T) therapy
Clinical Lymphoma Myeloma & Leukemia
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
John Kissel, MD
The Ohio State University Wexner Medical Center
Douglas Scharre, MD
The Ohio State University Wexner Medical Center
Kathleen Dungan, MD
The Ohio State University Wexner Medical Center
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”